Alopecia secondary to anti-tumor necrosis factor-alpha therapy
An. bras. dermatol
; An. bras. dermatol;90(2): 232-235, Mar-Apr/2015. graf
Article
em En
| LILACS
| ID: lil-741064
Biblioteca responsável:
BR1.1
ABSTRACT
Biologic drugs represent a substantial progress in the treatment of chronic inflammatory immunologic diseases. However, its crescent use has revealed seldom reported or unknown adverse reactions, mainly associated with anti-tumor necrosis factor (anti-TNF). Psoriasiform cutaneous reactions and few cases of alopecia can occur in some patients while taking these drugs. Two cases of alopecia were reported after anti-TNF therapy. Both also developed psoriasiform lesions on the body. This is the second report about a new entity described as 'anti-TNF therapy-related alopecia', which combines clinical and histopathological features of both alopecia areata and psoriatic alopecia. The recognition of these effects by specialists is essential for the proper management and guidance of these patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Psoríase
/
Doença de Crohn
/
Anti-Inflamatórios não Esteroides
/
Fator de Necrose Tumoral alfa
/
Alopecia
/
Anticorpos Monoclonais
Tipo de estudo:
Guideline
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
An. bras. dermatol
Assunto da revista:
DERMATOLOGIA
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Brasil